Pharmafile Logo

B2B sales

A doctor and a patient discussing something whilst looking at the ipad the doctor is holding.

The impact of mindset on digital product success: Download our new whitepaper

Six months on from releasing our research report, we reflect on the themes raised and offer practical advice on how contradictions can be overcome to enable digital success in pharma...

Graphite Digital

- PMLiVE

BioNTech to acquire UK AI start-up InstaDeep in deal worth over £560m

The deal will enable drug discovery and development of immunotherapies and vaccines

- PMLiVE

Genentech and Kronos Bio announce oncology partnership worth over $570m

The companies aim to advance novel therapies for transcriptional targets in oncology

- PMLiVE

AbbVie and Anima Biotech collaborate on mRNA biology modulators

The biotech could receive up to $540m in milestone payments for three targets

- PMLiVE

Research Partnership announces new CEO Gareth Phillips

Phillips was previously UK managing director and head of EMEA at Ipsos

- PMLiVE

Moderna and CytomX to partner in deal worth up to 1.2bn

The companies plan to develop mRNA-based therapies for a wide range of diseases

- PMLiVE

AstraZeneca to acquire CinCor Pharma in deal worth up to $1.8bn

The deal will strengthen AZ’s cardiorenal pipeline through the addition of baxdrostat

- PMLiVE

AbbVie and Immunome agree on multi-year oncology collaboration

The companies will identify up to ten antibody-target pairs using Immunome's discovery engine

- PMLiVE

Pfizer and Gero collaborate on fibrotic disease research

The companies will use data to identify genes and pathways linked to fibrotic diseases

- PMLiVE

Boehringer Ingelheim and 3T Biosciences in cancer research agreement

The immunotherapy company could receive $268m in milestone payments

- PMLiVE

SCIRIS ANNOUNCES APPOINTMENT OF NEW CEO

Porterhouse extends a very warm welcome to Isaac Batley

Porterhouse Medical Group

Virtual Tools for Promoting Diversity in Pharma and Clinical Trials

It is no secret that Pharma (still) has a major diversity problem.

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links